REMSleep Holdings Inc., a medical device company focused on sleep apnea treatment solutions, announced the passing of founder Thomas Wood and the appointment of Jeffrey Marshall as Chief Executive Officer. Wood, who founded the company and served as Chairman and CEO, passed away on February 26, 2026, after dedicating his career to developing better solutions for sleep apnea patients.
Wood's design journey began in 1981 with his first U.S. patent for a nasal air interface, eventually securing 26 patents for various CPAP interface components. His work culminated in the formation of REMSleep Holdings and the development of the DeltaWave Nasal Pillow System, which has received FDA 510(k) clearance and PDAC coding approval enabling Medicare reimbursement. Under Wood's leadership, the company built manufacturing and distribution infrastructure and positioned itself for commercial launch.
"Tom was more than a founder, he was a visionary and patient advocate who believed that sleep apnea patients deserved better options," said Anita Michaels, who has been elected Chairman of the Board. "His legacy lives on in the DeltaWave technology and in our commitment to bringing this innovation to the patients who need it." According to the company's website at https://www.REMSleep.com, the DeltaWave system represents the company's flagship product.
The Board of Directors has been reconstituted to ensure continuity, with Anita Michaels elected as Chairman. As Thomas Wood's sister, Chief Operating Officer, and majority shareholder, Michaels brings decades of experience with the company's technology and mission. Jeffrey Marshall, who has served as a strategy consultant to REMSleep since September 2025, has been appointed CEO and Director, bringing extensive industry experience in sales, marketing, and commercial strategy.
"This transition is a pivotal moment for REMSleep," said Marshall. "Tom built the foundation achieving FDA clearance, Medicare approval, and a differentiated product. Now it's our job to execute the commercial opportunity he created. The DeltaWave technology is ready for market, our infrastructure is in place, and we're focused on revenue generation and sustainable growth."
Marshall outlined immediate priorities including driving sales through strategic marketing plans, building brand awareness, and establishing partnerships with Durable Medical Equipment providers, physicians, and sleep labs. The leadership transition was planned prior to Wood's passing, with Wood working alongside Michaels and Marshall to establish systems and strategy for continuity.
The DeltaWave Nasal Pillow System represents the first product in what management envisions as a broader portfolio built on Wood's patented technologies. Beyond sleep apnea, Wood's vision extended to applying the same engineering principles to help patients with other chronic respiratory and neurological diseases, which has become part of the company's strategic roadmap.
"Tom's passing is a profound loss, but his work is far from finished," said Michaels. "We have a responsibility to our shareholders, to sleep apnea patients, and to Tom's memory to see this through. With Jeff's leadership and our reconstituted Board, REMSleep is well-positioned to deliver on the promise of the DeltaWave technology and develop the pipeline of products Tom envisioned."
